Page 2

Latest Lymphoma / Leukemia News From Medical News Today.

Total news: 25
Last news: August 30, 2007 07:00:00

Latest Leukemia News From News-Medical.Net

Total news: 10
Last news: August 30, 2007 09:29:00

Dana-Farber Cancer Institute scientists have identified a protein that prevents the bodys immune system from recognizing and attacking Hodgkin lymphoma cells. Based on this finding, the researchers are now investigating targeted therapies to disable this molecular "bodyguard" and boost a patients ability to fight the blood cancer. [click link for full article] - [Read more]

Medtronic, Inc. (NYSE: MDT) announced it has entered into a distribution and development agreement with Axon Systems, a privately-held developer of neuromonitoring technology used during spinal surgery. The agreement will allow Medtronic and Axon Systems to bring to market the next generation of surgeon directed and professionally supported spinal neuromonitoring technology and expand the availability of this critical technology. [click link for full article] - [Read more]

Overcoming pediatric cancer may only mark the beginning of a young survivors lifelong battle to stay healthy. While survivors of childhood acute lymphoblastic leukemia (ALL) face an increased risk of developing serious health complications as a result of their cancer treatment, for a variety of reasons many avoid simple exercise and healthy lifestyle changes that could reverse the damage, according to a team of researchers based at Memorial Sloan-Kettering Cancer Center. [click link for full article] - [Read more]

EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that it has commenced a Phase 1 study of MKC-1 in leukemia patients at the Princess Margaret Hospital, University Health Network (UHN), Toronto, Canada. Dr. Karen Yee, Assistant Professor, University of Toronto, is the principal investigator for the clinical trial. [click link for full article] - [Read more]

Preparing parents, both intellectually and emotionally, for the death of a child is closely linked to the parents future health, says an article published in this weeks Lancet Oncology (Special Paediatric Oncology Edition). We know little about when parents become *intellectually aware or *emotionally aware of their childs imminent death from cancer. [click link for full article] - [Read more]

Results from a clinical study conducted with patients who were diagnosed with advanced, refractory cutaneous T-cell lymphoma (CTCL) showed nearly a third of patients responded to treatment with ZOLINZA™ (vorinostat), as measured by objective response rate, according to data published in this weeks Journal of Clinical Oncology. [click link for full article] - [Read more]

Kinex Pharmaceuticals was notified today, by the U.S. Food and Drug Administration, that its Investigational New Drug, KX2-391, can proceed into Phase 1 Clinical Trials. "The rapid progress we have made in advancing this novel compound into human trials is extraordinary," said Dr. Allen Barnett, Chief Executive Officer of Kinex Pharmaceuticals. [click link for full article] - [Read more]

Genzyme Corp. (Nasdaq: GENZ) today announced that it has successfully completed its phase 3 trial of Mozobil(TM) (plerixafor) in non-Hodgkins lymphoma (NHL), and that the trial has robustly met its primary and secondary endpoints. The randomized, double-blind, placebo-controlled trial included 298 patients who were undergoing a hematopoietic stem cell transplant (HSCT) for NHL at medical centers in the United States and Canada. [click link for full article] - [Read more]

Combination therapy with fludarabine and cyclophosphamide for patients with chronic lymphocytic leukaemia (CLL) improves progression-free survival and response rates significantly, in comparison to monotherapy with just fludarabine or chlorambucil, according to a report in The Lancet this week. [click link for full article] - [Read more]

Infants less than one year old with acute lymphoblastic leukaemia have increased survival with a new treatment protocol, compared to those on conventional regimes, according to a report in this weeks medical journal The Lancet.Acute lymphoblastic leukaemia (ALL) in babies under one year of age is rare and biologically different from ALL in older babies and children. [click link for full article] - [Read more]

Leukaemia rates in children and young people are elevated near nuclear facilities, but no clear explanation exists to explain the rise, according to a research review published in the July issue of European Journal of Cancer Care. Researchers at the Medical University of South Carolina carried out a sophisticated meta-analysis of 17 research papers covering 136 nuclear sites in the UK, Canada, France, the USA, Germany, Japan and Spain. [click link for full article] - [Read more]

Leading childhood leukaemia charity, CHILDREN with LEUKAEMIA, has welcomed a new report from a Cross-Party Inquiry of senior backbench MPs, which they say adds unprecedented political support to the growing international scientific, medical and professional consensus that a precautionary building moratorium should be introduced to protect childrens health. The report, being launched in Parliament at 10. [click link for full article] - [Read more]

Cutaneous T-cell lymphoma, a rare and mysterious cancer, is on the rise, according to the first nationwide study of the disease in a decade.The study, conducted by researchers at the Providence VA Medical Center and The Warren Alpert Medical School of Brown University, found that 4,783 new cases of cutaneous T-cell lymphoma were diagnosed between 1973 and 2002, the period under review. The number of new cases grew substantially each decade, with incidence more than tripling. [click link for full article] - [Read more]

A new study has provided key insights into the complex molecular events that cause a deadly type of leukaemia and identifies promising new avenues to develop treatments for some of its variant forms. The research, carried out by scientists at The Institute of Cancer Research illuminates specific mechanisms involved in the development of acute promyelocytic leukaemia (APL). [click link for full article] - [Read more]